Stability of Amorphous Pharmaceutical Solids: Crystal Growth Mechanisms and Effect of Polymer Additives.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 380, doi. 10.1208/s12248-012-9345-6
- By:
- Publication type:
- Article
Works matching IS 15507416 AND DT 2012 AND VI 14 AND IP 3
Results: 33
1
2
Tissue Distribution Studies of Protein Therapeutics Using Molecular Probes: Molecular Imaging.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 389, doi. 10.1208/s12248-012-9348-3
- By:
- Publication type:
- Article
3
Ligand Binding Assays in the 21 Century Laboratory-A Call for Change.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
4
Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 400, doi. 10.1208/s12248-012-9352-7
- By:
- Publication type:
- Article
5
ADME of Biologics-What Have We Learned from Small Molecules?
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 410, doi. 10.1208/s12248-012-9353-6
- By:
- Publication type:
- Article
6
A Technique to Estimate In Vivo Dissolution Profiles Without Data from a Solution.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 433, doi. 10.1208/s12248-012-9355-4
- By:
- Publication type:
- Article
7
Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose-Response Models.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 420, doi. 10.1208/s12248-012-9349-2
- By:
- Publication type:
- Article
8
What about Pain in Disorders of Consciousness?
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 437, doi. 10.1208/s12248-012-9346-5
- By:
- Publication type:
- Article
9
Pharmacokinetic mAb-mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 445, doi. 10.1208/s12248-012-9357-2
- By:
- Publication type:
- Article
10
Pain Assessment in Human Fetus and Infants.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 456, doi. 10.1208/s12248-012-9354-5
- By:
- Publication type:
- Article
11
Predicting the Effects of Anti-angiogenic Agents Targeting Specific VEGF Isoforms.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 500, doi. 10.1208/s12248-012-9363-4
- By:
- Publication type:
- Article
12
Paradigm Shift in Toxicity Testing and Modeling.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 473, doi. 10.1208/s12248-012-9358-1
- By:
- Publication type:
- Article
13
Fish Drug Analysis-Phish-Pharm: 2011 Update.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 481, doi. 10.1208/s12248-012-9362-5
- By:
- Publication type:
- Article
14
Effects of Molecular Weight and Loading on Matrix Metalloproteinase-2 Mediated Release from Poly(Ethylene Glycol) Diacrylate Hydrogels.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 482, doi. 10.1208/s12248-012-9356-3
- By:
- Publication type:
- Article
15
In vitro-In Vivo Correlations: Tricks and Traps.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 491, doi. 10.1208/s12248-012-9359-0
- By:
- Publication type:
- Article
16
Toward Global Standards for Comparator Pharmaceutical Products: Case Studies of Amoxicillin, Metronidazole, and Zidovudine in the Americas.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 462, doi. 10.1208/s12248-012-9350-9
- By:
- Publication type:
- Article
17
Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ in Human Cerebrospinal Fluid.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 510, doi. 10.1208/s12248-012-9360-7
- By:
- Publication type:
- Article
18
Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 559, doi. 10.1208/s12248-012-9367-0
- By:
- Publication type:
- Article
19
Biopharmaceutic Planning in Pediatric Drug Development.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 519, doi. 10.1208/s12248-012-9364-3
- By:
- Publication type:
- Article
20
A Platform for Characterizing Therapeutic Monoclonal Antibody Breakdown Products by 2D Chromatography and Top-Down Mass Spectrometry.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 530, doi. 10.1208/s12248-012-9361-6
- By:
- Publication type:
- Article
21
Erratum to: Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
22
Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in Rats.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 543, doi. 10.1208/s12248-012-9366-1
- By:
- Publication type:
- Article
23
Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 554, doi. 10.1208/s12248-012-9369-y
- By:
- Publication type:
- Article
24
Nonclinical Dose Formulation: Out of Specification Investigations.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 523, doi. 10.1208/s12248-012-9347-4
- By:
- Publication type:
- Article
25
Population Pharmacokinetics and Pharmacodynamics of Ribavirin in Patients with Chronic Hepatitis C Genotype 1 Infection.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 571, doi. 10.1208/s12248-012-9368-z
- By:
- Publication type:
- Article
26
The Use of Modeling Tools to Drive Efficient Oral Product Design.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 591, doi. 10.1208/s12248-012-9372-3
- By:
- Publication type:
- Article
27
Glucocorticoid Receptor-Mediated Transcriptional Regulation of N-acetyltransferase 1 Gene Through Distal Promoter.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 581, doi. 10.1208/s12248-012-9370-5
- By:
- Publication type:
- Article
28
Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 601, doi. 10.1208/s12248-012-9373-2
- By:
- Publication type:
- Article
29
Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 612, doi. 10.1208/s12248-012-9374-1
- By:
- Publication type:
- Article
30
Physicochemical Characterization of Complex Drug Substances: Evaluation of Structural Similarities and Differences of Protamine Sulfate from Various Sources.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 619, doi. 10.1208/s12248-012-9375-0
- By:
- Publication type:
- Article
31
Re-introduction of a Novel Approach to the Use of Stable Isotopes in Pharmacokinetic Studies.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 639, doi. 10.1208/s12248-012-9371-4
- By:
- Publication type:
- Article
32
Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 646, doi. 10.1208/s12248-012-9378-x
- By:
- Publication type:
- Article
33
Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence.
- Published in:
- 2012
- By:
- Publication type:
- Report